Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SBAC✓SelectedUSD · SBACGSK vs SBAC performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs SBAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.1%
SBAC return
-21.8%
Excess return
+78.8%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioSBACExcessAlpha
1D-2.3%-6.5%+4.1%-0.8%
7D-3.0%-8.2%+5.2%-1.1%
30D+0.4%-6.1%+6.4%+1.7%
3M-1.2%-2.8%+1.7%-0.7%
6M+0.9%-10.8%+11.8%+3.3%
YTD+4.0%-7.4%+11.3%+5.2%
1Y+7.3%-8.5%+15.8%+8.9%
3Y+57.1%-20.3%+77.4%+60.1%
All+57.1%-21.8%+78.8%+60.1%

Cumulative growth

Daily Returns

Daily percentage return beside SBAC.

Daily Out/Under-Performance

Portfolio return minus SBAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling